Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kindstar Globalgene TechnologyHKSE:09960 +3.09%69 Days Inventory is 39.30 as of Dec. 2025, which is 11% above its 10-year median of 35.48. GuruFocus rates HKSE:09960 with a GF Score™ of 69/100 and a GF Value™ of HK$1.06 (Fairly Valued). The stock has 6 warning signs investors should review. Among 178 Medical Diagnostics & Research companies, Kindstar Globalgene Technology ranks better than 70.22% on this metric.
The historical rank and industry rank for Kindstar Globalgene Technology's Days Inventory or its related term are showing as below:
HKSE:09960'
s Days Inventory Range Over the Past 10 Years
Min: 26.65 Med: 35.48 Max: 38.7
Current: 38.08
During the past 8 years, Kindstar Globalgene Technology's highest Days Inventory was 38.70. The lowest was 26.65. And the median was 35.48.
HKSE:09960's Days Inventory is ranked better than 70.22% of 178
companies
in the Medical Diagnostics & Research industry
Industry Median: 68.595
vs HKSE:09960: 38.08
Inventory Turnover measures how fast the company turns over its inventory within a year.
Kindstar Globalgene Technology's Inventory Turnover for the
six
months ended in Dec. 2025 was 4.64.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kindstar Globalgene Technology's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.12.
Kindstar Globalgene Technology (HKSE:09960) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Kindstar Globalgene Technology's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kindstar Globalgene Technology's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Kindstar Globalgene Technology Days Inventory Related Terms
Kindstar Globalgene Technology Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kindstar Globalgene Technology Days Inventory Chart
HKSE:09960 vs TMO, DHR, NTRA: Days Inventory Comparison
For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kindstar Globalgene Technology Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's Days Inventory distribution charts can be found below:
* The bar in red indicates where Kindstar Globalgene Technology's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kindstar Globalgene Technology (HKSE:09960) has a Days Inventory of 39.30 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Kindstar Globalgene Technology and its competitors. This is 11% above median its historical median of 35.48. Over the past decade, Kindstar Globalgene Technology's Days Inventory has ranged from 26.65 to 38.70. According to the industry distribution chart, Kindstar Globalgene Technology ranks #53 out of 178 companies in the Medical Diagnostics & Research industry, placing it in the top 29.8%.
Is Kindstar Globalgene Technology's Days Inventory too high?
Kindstar Globalgene Technology's current Days Inventory of 39.30 is 11% above median its 10-year median of 35.48. Over the past 10 years, this metric has ranged from a low of 26.65 to a high of 38.70. The Medical Diagnostics & Research industry median Days Inventory is 68.60. Kindstar Globalgene Technology's value of 39.30 is 42.7% below this industry median. Based on the distribution chart, Kindstar Globalgene Technology ranks #53 out of 178 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Kindstar Globalgene Technology has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kindstar Globalgene Technology's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Kindstar Globalgene Technology ranks #53 out of 178 companies for Days Inventory. This puts Kindstar Globalgene Technology in the upper half of its industry. The industry median Days Inventory is 68.60. Kindstar Globalgene Technology's value of 39.30 is 42.7% below this benchmark. Historically, Kindstar Globalgene Technology's own Days Inventory has ranged from 26.65 to 38.70 over the past decade. While the company's 10-year median is 35.48 vs. the industry median of 68.60, Kindstar Globalgene Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 68.60, based on 178 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kindstar Globalgene Technology's current Days Inventory of 39.30 is 42.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Kindstar Globalgene Technology and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 68.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kindstar Globalgene Technology's current Days Inventory is 39.30, which is 11% above median its own 10-year median of 35.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kindstar Globalgene Technology stock overvalued right now?
Based on GuruFocus' analysis, Kindstar Globalgene Technology (HKSE:09960) is currently considered Fairly Valued. The stock's GF Value™ is HK$1.06, compared to a current price of HK$1.00 — trading 5.7% below its estimated fair value. The current Days Inventory is 39.30, which is 11% above median its 10-year median of 35.48 and 42.7% below the Medical Diagnostics & Research industry median of 68.60. Kindstar Globalgene Technology's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Kindstar Globalgene Technology (HKSE:09960), the current Days Inventory is 39.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kindstar Globalgene Technology (HKSE:09960) Overvalued in 2026?
Based on GuruFocus' analysis, Kindstar Globalgene Technology stock appears to be undervalued.
The current stock price of HK$1.00 is trading 5.7% below its estimated GF Value™ of HK$1.06.
GuruFocus considers Kindstar Globalgene Technology to be Fairly Valued.
Key valuation signals for HKSE:09960:
Days Inventory: 39.30 (11% above median its 10-year median of 35.48)
GF Value™: HK$1.06 vs. price of HK$1.00 (5.7% below fair value)
Industry Position: 42.7% below the Medical Diagnostics & Research median (#53 of 178)
No single metric tells the full story. See the HKSE:09960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kindstar Globalgene Technology Inc is engaged in the provision of clinical testing services in China. It operates in nine segments: Hematology testing segment includes testing services related to blood diseases; Genetic diseases and rare diseases segment includes testing services for rare diseases; Infectious diseases segment includes testing services from the infection department; Oncology segment includes testing related to oncology diseases; Neurology segment includes testing services related to neurological diseases undertaken by the Group; Maternity-related diseases segment includes testing services related to maternity; Routine testing segment conducts routine tests for the doctors daily diagnoses; CROs & R&D project segment includes research & develop services; & others segment.
69GF Score
Get the complete analysis for HKSE:09960
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09960 has been successfully added to your 
